- Gastroparesis is a chronic gastrointestinal disorder characterized by delayed gastric emptying without mechanical obstruction. It leads to symptoms such as nausea, vomiting, bloating, and abdominal pain, requiring both medical and surgical management strategies
- The demand for effective treatments is significantly driven by the global rise in diabetes cases, which is the leading cause of gastroparesis, along with growing diagnosis rates and improved treatment accessibility
- North America is expected to dominate the gastroparesis market due to advanced healthcare infrastructure, higher prevalence of diabetes, and early adoption of innovative therapies
- Asia-Pacific is expected to be the fastest growing region in the gastroparesis market during the forecast period due to increasing healthcare awareness, growing diabetic population, and expanding access to treatment
- Diabetic gastroparesis segment is expected to dominate the market with a market share of approximately 58.6% due to its strong correlation with diabetes and rising global incidence. As the most common form of the disease, continued advancements in drug classes and surgical procedures enhance patient outcomes
